Randhawa Simrat

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Randhawa Simrat's trades of Dianthus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01
PlS Planned sale
52,401 -34.2%
122.95
US$531,993 		52,401 -34.2% 122.95 US$531,993
2026-06-02 2026-06-01
PlS Planned sale
89,426 +10.2%
222.97
US$340,526 		89,426 +10.2% 222.97 US$340,526
2026-06-02 2026-06-01
PlS Planned sale
53,105 -39.2%
47.82
US$2,089,573 		53,105 -39.2% 47.82 US$2,089,573
2026-06-01 2026-06-01
PrS Proposed sale
26,530
93.01
US$2,467,555 		26,530 93.01 US$2,467,555
2026-03-13 2026-03-12
PlS Planned sale
33,830 -100.0%
81.48
US$2,756,468 		33,830 -100.0% 81.48 US$2,756,468
2026-03-12 2026-03-12
PrS Proposed sale
33,830
85.84
US$2,903,967 		33,830 85.84 US$2,903,967
2025-11-14 2025-11-14
PlS Planned sale
109,031 -96.5%
38.14
US$4,158,442 		109,031 -96.5% 38.14 US$4,158,442
2025-11-14 2025-11-13
PlS Planned sale
18,576 -82.3%
37.72
US$700,687 		18,576 -82.3% 37.72 US$700,687
2025-11-14 2025-11-13
PlS Planned sale
42,765 -65.4%
37.04
US$1,584,016 		42,765 -65.4% 37.04 US$1,584,016
2025-11-14 2025-11-13
PlS Planned sale
26,166 -28.6%
35.80
US$936,743 		26,166 -28.6% 35.80 US$936,743
2025-11-13 2025-11-13
PrS Proposed sale
196,538
38.72
US$7,609,951 		196,538 38.72 US$7,609,951
2023-09-25 2023-09-22
B Purchase
2,000 +100.0%
13.20
US$26,400 		2,000 +100.0% 13.20 US$26,400
2023-09-25 2023-09-21
B Purchase
2,000 +inf%
13.20
US$26,400 		2,000 +inf% 13.20 US$26,400